Medigen Vaccine Biologics Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 3.143 million compared to TWD 480,000 a year ago. Operating loss was TWD 283.164 million compared to TWD 127.248 million a year ago. Net loss was TWD 156.901 million compared to TWD 131.486 million a year ago. Basic loss per share was TWD 0.74 compared to TWD 0.75 a year ago.